Insmed Incorporated

Overview

Insmed Incorporated is a biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases, particularly those affecting the lungs. Founded in 1988 in Charlottesville, Virginia, it has evolved through strategic mergers and acquisitions, focusing on innovative inhaled formulations. The company's initial focus was on metabolic diseases, but over time, it shifted its emphasis to rare pulmonary conditions.

The company’s first approved product, an inhaled liposomal antibiotic, received FDA accelerated approval in 2018, followed by European approval in 2020 and a launch in Japan in 2021. With facilities in various locations, including Boulder, Colorado, and partnerships such as a worldwide license agreement with AstraZeneca, Insmed drives drug discovery, clinical development, and global commercialization to address unmet medical needs in rare diseases.

Basic Information

Contact Details

• Phone: +1 908-977-9900
• Website: insmed.com
• LinkedIn: linkedin.com/company/insmed

Key Focus Areas & Initiatives

• Biotechnology
• Orphan disease state
• Pharmaceuticals
• Chronic lung infections
• Pulmonary
• Biotechnology: pharmaceutical preparations
• Health care
• Biotechnology research
• Innovation
• Orphan drug
• Clinical research
• Investigator-initiated research
• Patient-centered
• Global healthcare
• Biotech pipeline
• Biotech development
• Targeted therapies
• Biotech research
• Rare diseases
• Fast track
• Liposomal drug delivery
• Healthcare technology
• RNA end-joining
• Healthcare
• Drug delivery systems
• Medical research
• Therapies for serious diseases
• Biotech
• Recombinant DNA technology
• Clinical development
• Talent acquisition
• Orphan drug designation
• Regulatory designations
• Metabolic disorders
• Pulmonary diseases
• Innovative science
• Investigational medicines
• Oncology therapies
• Medical innovation
• Biotech innovation
• Protein deimmunization
• Biopharmaceutical manufacturing
• Pharmaceutical and medicine manufacturing
• Biotech company
• Biotech manufacturing
• Liposomal encapsulation
• Targeted delivery
• Molecular biology
• Synthetic rescue
• Gene therapy
• Medical technology
• Regulatory approval
• Rare disease therapies
• Bioscience innovation
• Pulmonary antibiotics
• Recombinant protein
• Oncology research
• Biotech therapies
• Protein therapeutics
• Rare disease treatment
• Clinical trial transparency
• Clinical trials
• Investigational drugs
• Therapeutic development
• Biopharmaceutical research
• Metabolic therapy
• Biopharmaceutical
• Oncology
• Therapeutic pipeline
• Biopharmaceuticals
• Therapies
• Patient support
• Arikayce
• Brensocatib
• TPIP
• Early-stage research
• Inclusion
• Healthcare compliance
• Pharmaceutical development
• Drug development
• Life-altering medicines
• Patient advocacy
• Clinical data
• Orphan drugs
• Responsibility report
• Corporate governance
• FDA approval
• Healthcare accessibility
• Cultural diversity
• Patient-centric solutions
• Collaboration
• Accountability
• Passion
• Respect
• Integrity
• Employment opportunities
• Employee engagement
• Global expansion
• Discovery dialogues
• Scientific challenges
• Pipeline development
• Medical information
• Product complaints
• Cancer treatment
• Anti-infective therapies
• Personalized medicine
• Employee well-being
• Ethical leadership
• Community service
• Volunteer initiatives
• Well-being programs
• Medical
• Health, wellness & fitness
• Hospital & health care

Technologies Used

• 24-7 Media
• AI
• AMP
• AWS CloudFormation
• AWS Trusted Advisor
• Act!
• Amazon Web Services (AWS)
• Ansible
• Atlassian Cloud
• BASE
• CAT
• Cisco Secure Firewall Management Center
• Cisco Unified Intelligence Center
• Confluence
• Docker
• Electron
• Elementor
• Enom
• Express
• Facebook Custom Audiences
• Facebook Login (Connect)
• Facebook Widget
• Flow
• Git
• GitHub
• GitHub Copilot
• Google Analytics
• Google Cloud Data Loss Prevention
• Google Cloud Hosting
• Google Cloud Platform
• Google Font API
• Google Kubernetes Engine
• Google Tag Manager
• HPLC
• IBM ILOG CPLEX Optimization Studio
• IDC
• Illumina
• Instagram
• Intel Nios
• JMP
• Jenkins
• Kubernetes
• LabWare LIMS
• LinkedIn Learning
• Linkedin Marketing Solutions
• Microsoft Active Directory Federation Services
• Microsoft Advanced Group Policy Management
• Microsoft Azure Monitor
• Microsoft Office
• Microsoft PowerShell
• Mimecast
• Mist
• Mobile Friendly
• Multilingual
• New Relic
• Nginx
• Ning
• NuGenesis SDMS
• Olo
• Piwik
• Progress Chef
• Puppet
• Python
• Qubit Deliver
• Rackspace MailGun
• React
• Remote
• SAP Crystal Solutions
• SAS Enterprise Guide
• Salesforce
• ServiceNow
• SignalR
• Slack
• Snyk
• SonarQube
• Terraform
• Tor
• Typekit
• VMware
• Veeam
• Veeva CRM
• Veeva Systems
• Veeva Vault eTMF
• Vimeo
• VueJS
• WP Engine
• Wagtail CMS
• WordPress.org
• Workday
• Workday Recruit
• iCIMS
• reCAPTCHA

Affiliated Organizations & Regional Branches

• Adrestia Therapeutics Ltd.